Back
Atara Biotherapeutics Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Sell
10
ATRA
Atara Biotherapeutics
Last Price:
0.53
Seasonality Move:
1.95%
Sell
14
NBY
NovaBay Pharmaceuticals
Last Price:
0.08
Seasonality Move:
1.9%
Sell
10
Atara Biotherapeutics (ATRA)
is a Sell
Is Atara Biotherapeutics a Buy, Sell or Hold?
- The current Atara Biotherapeutics [ATRA] share price is $0.53. The Score for ATRA is 10, which is 80% below its historic median score of 50, and infers higher risk than normal.
- ATRA is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
14
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
- The current NovaBay Pharmaceuticals [NBY] share price is $0.08. The Score for NBY is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
- NBY is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
ATRA Stock Price Chart
What is Atara Biotherapeutics's stock price today?
-
The Atara Biotherapeutics share price today is $0.53
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ATRA is experiencing selling pressure, which indicates risk of future bearish movement.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.08
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing selling pressure, which indicates risk of future bearish movement.
ATRA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.04 | Sell |
Relative Strength Index (14 RSI): | 28.88 | Sell |
Chaikin Money Flow: | -1856063 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.62 - 0.74) | Sell |
Bollinger Bands (100): | (0.56 - 0.82) | Sell |
NBY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.01 | Sell |
Relative Strength Index (14 RSI): | 38.85 | Sell |
Chaikin Money Flow: | -1654308 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.07 - 0.09) | Buy |
Bollinger Bands (100): | (0.1 - 0.18) | Sell |
ATRA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.61 | Sell |
20-day SMA: | 0.66 | Sell |
50-day SMA: | 0.69 | Sell |
200-day SMA: | 1.01 | Sell |
8-day EMA: | 0.6 | Sell |
20-day EMA: | 0.65 | Sell |
50-day EMA: | 0.69 | Sell |
200-day EMA: | 1.18 | Sell |
NBY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.09 | Sell |
20-day SMA: | 0.08 | Sell |
50-day SMA: | 0.11 | Sell |
200-day SMA: | 0.3 | Sell |
8-day EMA: | 0.09 | Sell |
20-day EMA: | 0.09 | Sell |
50-day EMA: | 0.11 | Sell |
200-day EMA: | 0.52 | Sell |
Atara Biotherapeutics Earnings Growth & ATRA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.28 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.43 per share, and an increase next year of $0.73 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.35 per share, an increase next quarter of $0.06 per share, an increase this year of $2.04 per share, and an increase next year of $0.30 per share.
Atara Biotherapeutics Technical Analysis
Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
NovaBay Pharmaceuticals Technical Analysis
Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |